Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Bullboard Posts
Post by Kuhlhauson Nov 10, 2009 5:12pm
530 Views
Post# 16472781

TSX Venture Market Mover...

TSX Venture Market Mover...We cracked the top 10 list today on the Venture - largest percentage gainer and number 8 in share volume!!!

This will generate substantial attention (as it did back in May, and what drew me here back then). Momentum will carry especially if the opening volume tomorrow morning is high and positive.

If we're lucky early trading will shake the penny flippers and we'll get one last chance to pick up shares on the dip to
.14 (was resistance) before we break through
.20 to a new 52 week high - clear sailing after that!

Welcome all you new speculators, do your DD and you will understand the potential inherent value we have here.

Cheers,
K.

Bullboard Posts